Is the Xulane (norelgestromin/ethinyl estradiol) transdermal patch an effective form of birth control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Xulane is an Effective Form of Birth Control

Xulane (norelgestromin/ethinyl estradiol transdermal patch) is an FDA-approved combined hormonal contraceptive that effectively prevents pregnancy when used correctly. 1

Efficacy and Effectiveness

The Xulane patch delivers 150 μg of norelgestromin and 35 μg of ethinyl estradiol daily and works by suppressing ovulation, thickening cervical mucus, and altering the endometrium 2, 1. With typical use, approximately 9 out of 100 women become pregnant in the first year, which is comparable to combined oral contraceptives 2. With perfect use, the failure rate is less than 1% 3.

Important Efficacy Limitations:

  • The patch may be less effective in women weighing ≥198 lbs (90 kg) 1
  • The patch is contraindicated in women with BMI ≥30 kg/m² due to increased VTE risk 1

How to Use Xulane

The patch is applied once weekly for 3 consecutive weeks, followed by 1 patch-free week 2, 3. It can be placed on the abdomen, upper torso, upper outer arm, or buttocks 3.

Timing and Backup Contraception:

  • If started within the first 5 days of menstrual bleeding: No backup contraception needed 2
  • If started >5 days after menstrual bleeding started: Use backup contraception (condoms) for 7 days 2

Managing Delayed Application or Detachment:

If patch is detached or delayed <48 hours 2:

  • Apply new patch immediately
  • Keep same patch change day
  • No backup contraception needed

If patch is detached or delayed ≥48 hours 2:

  • Apply new patch immediately (starts new cycle)
  • Use backup contraception for 7 consecutive days
  • Consider emergency contraception if unprotected intercourse occurred

Safety Considerations

Critical Warnings:

Do not use Xulane if you 1:

  • Smoke cigarettes and are over 35 years old (increased cardiovascular risk)
  • Have BMI ≥30 kg/m² (increased VTE risk)
  • Have history of blood clots, stroke, or heart attack
  • Have uncontrolled hypertension
  • Have certain migraine types (with aura or any migraine if >35 years)

Estrogen Exposure Concern:

The patch delivers approximately 60% more estrogen than a typical 35 μg oral contraceptive 1. Studies suggest a possible 1.2-2.2 times increased risk of venous thromboembolism compared to low-dose combined oral contraceptives 3. However, the absolute risk remains low, and this must be weighed against the risks of unintended pregnancy 3.

Advantages Over Oral Contraceptives

  • Better compliance: Weekly application versus daily pill-taking 3
  • More consistent hormone levels: Less peaks and troughs compared to oral contraceptives 4
  • Not affected by vomiting or diarrhea: Unlike oral contraceptives 2

Common Side Effects

Side effects are typical of combined hormonal contraceptives but include 5, 6:

  • Breast tenderness (more common than with pills, especially first 2 cycles)
  • Application site reactions (unique to patch; 1.9% discontinuation rate)
  • Nausea, headache, breakthrough bleeding
  • Most side effects are mild-to-moderate and not treatment-limiting

Special Populations

Breastfeeding women: Should not use during first 3 weeks postpartum (increased VTE risk) and generally should not use during week 4 (may reduce milk production) 2. Consider alternative contraception until breastfeeding is well-established 1.

Postpartum non-breastfeeding women: Can start ≥21 days postpartum if not at increased VTE risk 2.

Drug Interactions

The following medications may reduce patch effectiveness 1:

  • Certain seizure medications (carbamazepine, phenytoin, topiramate)
  • Rifampin, rifabutin
  • Some HIV medications
  • St. John's wort

Use backup contraception when taking these medications 1.

Bottom Line

Xulane is an effective contraceptive option for women with BMI <30 kg/m² who prefer weekly rather than daily dosing, with efficacy comparable to combined oral contraceptives. The main caveats are the contraindication in women with BMI ≥30 kg/m², potentially reduced efficacy in women ≥198 lbs, higher estrogen exposure with possible increased VTE risk, and the requirement for proper application technique. For women who meet eligibility criteria and desire autonomy from daily pill-taking, the patch provides reliable pregnancy prevention with good cycle control 2, 5.

Related Questions

How is a transdermal contraceptive patch (containing ethinyl estradiol and norelgestromin) applied, what is the weekly replacement schedule, and what are the contraindications for its use?
Should I remove a contraceptive transdermal patch if there is bleeding at the application site?
What are the available dose strengths of the Evorel Conti (norelgestromin/ethinyl estradiol) contraceptive patch?
How often should the Climara (ethinyl estradiol/norelgestromin) transdermal contraceptive patch be changed?
How do I start using birth control patches?
In a 43-year-old female with right hypochondrial abdominal pain, a normal abdominal ultrasound, Hashimoto thyroiditis, a mildly elevated fasting gastrin level (153 pg/mL), and mildly elevated triglycerides, what is the differential diagnosis?
Which of the following is NOT an indication for carotid endarterectomy or carotid artery stenting: A) High‑grade stenosis (70–99%) on the side of the ischemic event, B) Endovascular stenting carries a higher risk of intra‑operative stroke, C) Symptomatic carotid disease with moderate stenosis (50–69%), D) Asymptomatic carotid stenosis of 50–69%, or E) Right hemiparesis with ipsilateral high‑grade carotid stenosis (>70%)?
In a patient with chronic kidney disease stage 4, what B-type natriuretic peptide (BNP) level is considered normal and how should elevated values be interpreted?
Is pancreatic inflammation commonly observed on abdominal ultrasound in patients with enteric (typhoid) fever?
What should be added to carvedilol 25 mg if blood pressure is not controlled?
What is the diagnosis and appropriate treatment plan for a 22-year-old male presenting with acute severe psychosis (auditory hallucinations, persecutory and bizarre delusions, ideas of reference), comorbid major depressive disorder, anxiety, post‑traumatic stress disorder, chronic THC use, a family history of schizophrenia, and recent non‑compliance with psychiatric medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.